Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field

A technology of cell subsets and heart cells, which can be used in medical preparations containing active ingredients, animal cells, vertebrate cells, etc., and can solve problems such as affecting the background separation process.

Pending Publication Date: 2020-02-11
奥洛克治疗有限责任公司
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] The authors of the present invention have now developed a method for the isolation of human cardiac progenitor cell subpopulations (hCPCs) that resolves different technical issues affecting the background isolation process, especially in obtaining clinically meaningful hCPC numbers and high Efficiency Aspects of Purity Standards

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field
  • Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field
  • Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0097][Example 1: Method for Isolating Human Cardiac Progenitor Cell Population by Positive Selection]

[0098] 【Materials and methods】

[0099] 【Primary culture】

[0100] Samples of auricles weighing between 36.8 and 631.8 mg were collected in the operating room (see figure 1 ), and immediately transfer to a sterile solution containing at least one sterile solution (phosphate-buffered saline, PBS, or physiological solution), preferably one that also maintains tissue viability (such as any medium) to prevent its dehydration in the container.

[0101] Alternatively, another solution comprising bovine serum albumin (BSA) or human serum albumin (HSA) or fetal bovine serum (FBS) may also be used. From then on, samples can be kept at controlled temperature (+4 °C) and processed within 48 h, or frozen in a solution containing at least FBS and DMSO in liquid nitrogen, since freezing has no bearing on whether cultures are obtained impact (see Figure 6 a-b). For processing, aft...

Embodiment 2

[0135] [Example 2: Method for Isolating Human Cardiac Progenitor Cell Population by Negative Selection]

[0136] Before selection, the steps of fragment digestion, primary culture and amplification were the same as in Example 1.

[0137] 【Isolate a population of interest by negative selection】

[0138] Isolate the population to be isolated from the dish using a non-enzymatic method (see section "Expansion of non-selected populations"), count the cells and resuspend in cold isolation buffer (WB); 7 Resuspend the cells at a concentration of 100 μl.

[0139] Before negative selection, a fraction of cells (100,000) were used for fluorescence activated cell sorting (FACS) analysis. Cells are labeled with immunoglobulin (isotype IgG) conjugated with the same fluorescent molecule as the antibody (in this example FITC, BD) that recognizes the target population, 1 μl of antibody, and incubated at room temperature in Incubate for 15 minutes in the dark or with anti-biotin FITC (Milte...

Embodiment 3

[0150] [Example 3: Method for Isolating Human Cardiac Progenitor Cell Populations by Combined Positive and Negative Selection]

[0151] Before selection, the steps of fragment digestion, primary culture and amplification were the same as in Example 1.

[0152] [Isolate the population of interest by combining positive and negative selection]

[0153] Isolate the population to be isolated from the dish using a non-enzymatic method (see section "Expansion of non-selected populations"), count the cells and resuspend in cold isolation buffer (WB); 7 cells without resuspending the cells at a concentration of 100 μl.

[0154] Prior to selection, a fraction of the cells (400,000) were subjected to fluorescence-activated cell sorting (FACS) analysis ( Figure 11 A-E). Subsequently, the cells were divided into four different tubes.

[0155] The first tube (identified as isotype FITC) is labeled with an immunoglobulin (isotype IgG) that binds to the same fluorescent molecule that bin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for the isolation of subpopulations of cardiac progenitor cells from a heart tissue sample, the population thus obtained and the related uses in the medical field for the cell therapy or cardiac cell and / or tissue transplantation field.

Description

【Technical field】 [0001] The present invention relates to a method for isolating a subpopulation of cardiac progenitor cells from a sample of cardiac tissue, the population thus obtained and the related use in the field of cell therapy or cardiac cell and / or tissue transplantation in the medical field. 【Background technique】 [0002] Progenitor cells are all cell populations that have the ability to proliferate and differentiate, and also have a support function for surrounding cells and tissues. [0003] Progenitor cells are rare cells located in biological tissues that maintain their function by exchanging damaged cells. They were originally found in tissues with the highest rates of cell exchange, such as bone marrow and epithelial tissues, but it is now known that populations of progenitor cells present in different tissues also have reduced regenerative capacity. [0004] The discovery of progenitor cells residing in the adult heart has revolutionized the dogma of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/077A61K35/34
CPCA61K35/34C12N5/0657C12N2500/30G01N1/286C12N2501/115G01N2001/2873C12N2501/14G01N33/56966
Inventor G·蓬皮利奥E·甘比尼G·斯帕尔特罗
Owner 奥洛克治疗有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com